A PROSPECTIVE PHASE II STUDY OF INDUCTION ERLOTINIB THERAPY IN STAGE IIIA-N2 NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Zhong, W. -Z.
Yang, X. -N.
Liao, R. -Q.
Nie, Q.
Su, J.
Zhang, X. -C.
An, S. -J.
Zhou, Q.
Yang, J. -J.
Wu, Y. -L.
机构：
[1] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study
    Wan-Qin Zeng
    Wen Feng
    Li Xie
    Chen-Chen Zhang
    Wen Yu
    Xu-Wei Cai
    Xiao-Long Fu
    Lung, 2019, 197 : 741 - 751
  • [42] PHASE II TRIAL EVALUATING GEMCITABINE-IFOSFAMIDE-CISPLATIN AS INDUCTION TREATMENT FOR MEDIASTINOSCOPY PROVEN STAGE IIIA-N2 NON-SMALL CELL LUNG CANCER
    Derijcke, Sofie
    Vansteenkiste, Johan
    De Leyn, Paul
    Lievens, Yolande
    Nackaerts, Kristiaan
    Dooms, Christophe
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1579 - S1580
  • [43] Optimal Treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: A Neverending Story?
    Van Schil, Paul E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1338 - 1340
  • [44] Postoperative radiotherapy in non-small cell lung cancer stage IIIA-N2: Focus and perspectives
    Wang, Pascal
    Duchemann, Boris
    Chouahnia, Kader
    Matton, Lise
    Benabadji, Ambre
    Zelek, Laurent
    Popotte, Hosni
    Paix, Adrien
    BULLETIN DU CANCER, 2023, 110 (01) : 101 - 112
  • [45] Postoperative Radiotherapy in Completely Resected Stage IIIA-N2 Non-Small Cell Lung Cancer
    Ahn, S.
    Na, K.
    Kim, Y.
    Song, S.
    Oh, I.
    Park, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2180 - S2181
  • [46] Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!
    Berzenji, Lawek
    Beckers, Paul
    Van Schil, Paul E.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1153 - S1156
  • [47] Phase II study of chemoradiation therapy and erlotinib for stage Ill non-small cell lung cancer
    Komaki, Ritsuko U.
    Wistuba, Ignacio
    Tang, Xi Ming
    Meyn, Raymond E.
    Lee, J. Jack
    Wei, Xiong
    Allen, Pamela K.
    O'Reilly, Michael S.
    Welsh, James
    Hong, Wuan Ki
    CANCER RESEARCH, 2011, 71
  • [48] Management of non-small-cell lung cancer (stage IIIa)
    Gridelli, C
    Rossi, A
    Guerriero, C
    Ferrara, C
    Del Gaizo, F
    Colantuoni, G
    Salerno, V
    Nicolella, D
    TUMORI JOURNAL, 2003, : S103 - S105
  • [49] Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
    Senan, S.
    Ozguroglu, M.
    Daniel, D.
    Villegas, A.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Faivre-Finn, C.
    Paz-Ares, L.
    Wu, Y. L.
    Mann, H.
    Dennis, P. A.
    Antonia, S. J.
    ESMO OPEN, 2022, 7 (02)
  • [50] Postoperative Radiation Therapy for Elderly Patients With Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer
    Hui, Z.
    Dai, H.
    Liang, J.
    Lv, J.
    Zhou, Z.
    Feng, Q.
    Xiao, Z.
    Chen, D.
    Zhang, H.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S523 - S523
12345